Characterization of Potent ABCG2 Inhibitor Derived from Chromone: From the Mechanism of Inhibition to Human Extracellular Vesicles for Drug Delivery

• Egile Nagusiak: Glaucio Valdameri (Egilea), Diogo Henrique Kita (Egilea), Julia de Paula Dutra (Egilea), Diego Lima Gomes (Egilea), Arun Kumar Tonduru (Egilea), Thales Kronenberger (Egilea), Bruno Gavinho (Egilea), Izadora Volpato Rossi (Egilea), Mariana Mazetto de Carvalho (Egilea), Basile Pérès (Egilea), Ingrid Fatima Zattoni (Egilea), Fabiane Gomes de Moraes Rego (Egilea), Geraldo Picheth (Egilea), Rilton Alves de Freitas (Egilea), Antti Poso (Egilea), Suresh V. Ambudkar (Egilea), Marcel I. Ramirez (Egilea), Ahcène Boumendjel (Egilea), Vivian Rotuno Moure (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2023-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Inhibition of ABC transporters is a promising approach to overcome multidrug resistance in cancer. Herein, we report the characterization of a potent ABCG2 inhibitor, namely, chromone <b>4a</b> (<b>C4a</b>). Molecular docking and in vitro assays using ABCG2 and P-glycoprotein...